Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Histologic Features Guide Prognosis of Childhood Medulloblastomas

By LabMedica International staff writers
Posted on 20 Nov 2008
Specific histologic features of childhood tumors called medulloblastomas may provide insight into prognoses. More...


Medulloblastomas are common, malignant, embryonal tumors in the cerebellum. Individual histologic features such as nodules, balls, or high cell density are used to divide the tumors into variants thought to modify survival estimates.

Scientists found a difference in survival distribution for six features of medulloblastomas: high cell density, fine fibrillary stroma, necrosis, nodules, balls, and prominent nucleoli. The presence of nodules, balls, fine fibrillary stroma, and high cell density improved the survival outlook, whereas necrosis and prominent nucleoli worsened it.

The World Health Organization (WHO; Geneva, Switzerland) classification of these tumors includes desmoplastic/nodular (DM), medulloblastoma with extensive nodularity (N), large cell medulloblastoma (LC), and anaplastic medulloblastoma (A).

"The presence of nodularity in medulloblastoma is important to improved survival likelihood, particularly when combined with balls and fine fibrillary stroma,” wrote Dr. Floyed H. Giles M.D. from the neuropathology department at the Children's Hospital, Los Angeles, (Los Angeles, CA, USA) and colleagues in an article published in the November 13, 2008, issue of the journal Pediatric and Developmental Pathology. "Given the WHO-acknowledged ‘overlap' of desmoplastic/nodular medulloblastoma and nodular medulloblastoma, we suggest these diagnoses be combined into a diagnosis of nodular medulloblastoma, with nodules, balls, and fine fibrillary stroma as defining criteria.”

The investigators contend that three histologic features vital for LC and A diagnoses--large and intermediate size nuclei and prominent nucleoli--have poor read-reread reliability and suggest these be combined into a diagnosis of anaplastic/large cell medulloblastoma.

Related Links:
World Health Organization
Children's Hospital Los Angeles



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.